Q3 2019 Holdings
Filed 2019-11-13 | 19 holdings | $59.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $23.6M | 245,424 | 40.1% |
| Cytokinetics Incorporated(CYTK) | COM NEW | 23282W605 | $21.6M | 1,898,970 | 36.6% |
| Alector, Inc.(ALEC) | COM | 014442107 | $13.5M | 936,371 | 22.9% |
| Turning Point Therapeutics, Inc. | COM | 90041T108 | $68.7K | 1,826,374 | 0.1% |
| Aerie Pharmaceuticals, Inc.(AERIEUR) | COM | 00771V108 | $26.9K | 1,400,900 | 0.0% |
| Insmed Incorporated(INSM) | COM | 457669307 | $25.2K | 1,429,518 | 0.0% |
| The Medicines Company | COM | 584688105 | $23.9K | 478,217 | 0.0% |
| Biohaven Pharmaceutical Holding Company Ltd.(BHVN) | COM | G11196105 | $17.8K | 425,794 | 0.0% |
| OptiNose, Inc. | COM | 68404V100 | $15.7K | 2,238,006 | 0.0% |
| Voyager Therapeutics, Inc.(VYGR) | COM | 92915B106 | $14.3K | 830,565 | 0.0% |
| Myokardia, Inc. | COM | 62857M105 | $12.4K | 238,186 | 0.0% |
| Fulcrum Therapeutics, Inc.(FULC) | COM | 359616109 | $11.2K | 1,687,500 | 0.0% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $10.5K | 2,060,268 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $6.6K | 557,700 | 0.0% |
| Rhythm Pharmaceuticals, Inc.(RYTM) | COM | 76243J105 | $5.1K | 234,482 | 0.0% |
| Immunomedics, Inc.(IMMU) | COM | 452907108 | $4.9K | 367,636 | 0.0% |
| Si-Bone, Inc.(SIBN) | COM | 825704109 | $3.6K | 205,621 | 0.0% |
| Aerie Pharmaceuticals, Inc.(AERIEUR)Call | COM | 00771V108 | $1.9K | 100,500 | 0.0% |
| Aerie Pharmaceuticals, Inc.(AERIEUR)Put | COM | 00771V108 | $1.9K | 100,500 | 0.0% |